As you might recall The Farber Center for Radiation Oncology was the first in NYC to treat patients with AccuBoost, an image-guided treatment for breast cancer. The process uses digital mammography for localization and surface applications for the delivery of radiation. Prior to AccuBoost, partial breast irradiation treatment was performed via invasive techniques such as employing multiple protruding catheters or with inflatable balloon devices implanted into the breast. AccuBoost is the first technology to allow High Dose Rate (HDR) treatment of breast cancer in a Non-Invasive way.
Now The Farber Center for Radiation Oncology will take part as a clinical site with Brown University Oncology Group in an AccuBoost Study designed to evaluate the toxicity, recurrence, and cosmetic outcome of AccuBoost as a form of non-invasive accelerated partial breast irradiation (APBI). The faculty in the department of Radiation Oncology at Rhode Island Hospital and Brown University is among international experts in partial breast irradiation and has had expertise in this field that spans several decades. We are proud to be working with them.
Whole breast radiation therapy as a standard technique for adjuvant RT following breast conservation surgery is typically daily treatments for 3.5 weeks to 6.5 weeks. The AccuBoost accelerated partial breast irradiation reduces the volume of breast tissue treated and surrounding organs (heart, lung), in a shorter treatment time (10 treatments over 5-10 days). Patients can be treated twice a day for 5 days or once a day for 10 days in place of whole breast radiation therapy.
We will be looking for patients to participate in the study that fill the following criteria:
Patients referred for adjuvant radiation therapy who are diagnosed as early stage node negative hormone receptor positive with:
1. A confirmed histological diagnosis of invasive breast carcinoma or DCIS
2. Age greater or equal to 50 years old
3. Treated by breast conserving surgery with axillary node dissection or sentinel lymph node biopsy
If you are interested in participating in the study please contact The Farber Center for Radiation Oncology at 212 300-0663 to schedule a consultation.










